
### [NCIT:C7114](http://purl.obolibrary.org/obo/NCIT_C7114)
**Label:** Thymoma Type B

**Subclasses:** [NCIT:C6889](http://purl.obolibrary.org/obo/NCIT_C6889) (Malignant Type B2 Thymoma), [NCIT:C7997](http://purl.obolibrary.org/obo/NCIT_C7997) (Thymoma Type B3), [NCIT:C7996](http://purl.obolibrary.org/obo/NCIT_C7996) (Malignant Type B1 Thymoma), [NCIT:C6888](http://purl.obolibrary.org/obo/NCIT_C6888) (Thymoma Type B2), [NCIT:C6887](http://purl.obolibrary.org/obo/NCIT_C6887) (Thymoma Type B1), 

**Class expressions from DL-Learner:**

- [NCIT:C61000](http://purl.obolibrary.org/obo/NCIT_C61000) (Neoplastic Epithelial Large Polygonal Cell) 57.14%
- [NCIT:C60998](http://purl.obolibrary.org/obo/NCIT_C60998) (Neoplastic Epithelial Small Oval Cell) 57.14%
- Thing 53.80%
- [NCIT:C61002](http://purl.obolibrary.org/obo/NCIT_C61002) (Malignant Epithelial Medium-Sized Polygonal Cell) 53.57%
- [NCIT:C61001](http://purl.obolibrary.org/obo/NCIT_C61001) (Malignant Epithelial Large Polygonal Cell) 53.57%
- [NCIT:C60999](http://purl.obolibrary.org/obo/NCIT_C60999) (Malignant Epithelial Small Oval Cell) 53.57%
- [NCIT:C60991](http://purl.obolibrary.org/obo/NCIT_C60991) (Malignant Epithelial Oval Cell) and [NCIT:C60998](http://purl.obolibrary.org/obo/NCIT_C60998) (Neoplastic Epithelial Small Oval Cell) 53.57%
- [NCIT:C60990](http://purl.obolibrary.org/obo/NCIT_C60990) (Neoplastic Epithelial Oval Cell) 42.50%
- [NCIT:C37036](http://purl.obolibrary.org/obo/NCIT_C37036) (Neoplastic Epithelial Polygonal Cell) 39.58%
- [NCIT:C60991](http://purl.obolibrary.org/obo/NCIT_C60991) (Malignant Epithelial Oval Cell) 38.93%
- [NCIT:C60991](http://purl.obolibrary.org/obo/NCIT_C60991) (Malignant Epithelial Oval Cell) and (not ([NCIT:C39066](http://purl.obolibrary.org/obo/NCIT_C39066) (Erythropoietin Neuroprotection Pathway))) 38.93%
- [NCIT:C60991](http://purl.obolibrary.org/obo/NCIT_C60991) (Malignant Epithelial Oval Cell) and (not ([NCIT:C39059](http://purl.obolibrary.org/obo/NCIT_C39059) (Map Kinase Inactivation of SMRT Corepressor Pathway))) 38.93%
- [NCIT:C60991](http://purl.obolibrary.org/obo/NCIT_C60991) (Malignant Epithelial Oval Cell) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 38.93%
- [NCIT:C60991](http://purl.obolibrary.org/obo/NCIT_C60991) (Malignant Epithelial Oval Cell) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 38.93%
- [NCIT:C60991](http://purl.obolibrary.org/obo/NCIT_C60991) (Malignant Epithelial Oval Cell) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 38.93%


